Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Granular aluminium as a superconducting material for high-impedance quantum circuits.

Grünhaupt L, Spiecker M, Gusenkova D, Maleeva N, Skacel ST, Takmakov I, Valenti F, Winkel P, Rotzinger H, Wernsdorfer W, Ustinov AV, Pop IM.

Nat Mater. 2019 Aug;18(8):816-819. doi: 10.1038/s41563-019-0350-3. Epub 2019 Apr 29.

PMID:
31036961
2.

[Antithrombotic treatment in acute coronary syndrome and atrial fibrillation].

Darius H, Görge G, Spiecker M, Schinzel H.

Herz. 2019 Feb;44(1):29-34. doi: 10.1007/s00059-019-4781-z. German.

PMID:
30689009
3.

Rapid nonlinear image scanning microscopy.

Gregor I, Spiecker M, Petrovsky R, Großhans J, Ros R, Enderlein J.

Nat Methods. 2017 Nov;14(11):1087-1089. doi: 10.1038/nmeth.4467. Epub 2017 Oct 16.

PMID:
29039418
4.

The use of paclitaxel coated balloon (PCB) in acute coronary syndrome of small vessel de novo lesions: an analysis of a prospective 'real world' registry.

Mahmood Zuhdi AS, Zeymer U, Waliszewski M, Spiecker M, Ismail MD, Boxberger M, Ferrari M, Zainal Abidin I, Wan Ahmad WA.

Springerplus. 2016 Mar 25;5:373. doi: 10.1186/s40064-016-2014-y. eCollection 2016.

5.

Prospective 'real world' registry for the use of the 'PCB only' strategy in small vessel de novo lesions.

Zeymer U, Waliszewski M, Spiecker M, Gastmann O, Faurie B, Ferrari M, Alidoosti M, Palmieri C, Heang TN, Ong PJ, Dietz U.

Heart. 2014 Feb;100(4):311-6. doi: 10.1136/heartjnl-2013-304881. Epub 2013 Nov 26.

PMID:
24281754
6.

The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.

Börgel J, Bulut D, Hanefeld C, Neubauer H, Mügge A, Epplen JT, Holland-Letz T, Spiecker M.

BMC Cardiovasc Disord. 2008 Dec 23;8:41. doi: 10.1186/1471-2261-8-41.

7.

How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses?

Lindstaedt M, Spiecker M, Perings C, Lawo T, Yazar A, Holland-Letz T, Muegge A, Bojara W, Germing A.

Int J Cardiol. 2007 Aug 21;120(2):254-61. Epub 2007 Mar 7.

PMID:
17346818
8.

[Angiographic assessment of functionally insignificant left main coronary artery stenoses: reliability compared to intracoronary pressure measurement].

Lindstaedt M, Spiecker M, Lawo T, Yazar A, Mügge A, Bojara W, Germing A.

Dtsch Med Wochenschr. 2006 Sep 29;131(39):2134-8. German.

PMID:
16991027
9.

Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.

Spiecker M, Liao J.

Trends Cardiovasc Med. 2006 Aug;16(6):204-8. Review.

PMID:
16839864
10.

Heart failure in elderly patients.

Spiecker M.

Exp Gerontol. 2006 May;41(5):549-51. Epub 2006 Apr 18. Review.

PMID:
16621389
11.

Doppler echocardiographic prediction of recurrent atrial fibrillation following cardioversion.

Spiecker M, Böhm S, Börgel J, Grote J, Görlitz S, Huesing A, Mügge A.

Int J Cardiol. 2006 Nov 10;113(2):161-6. Epub 2005 Dec 5.

PMID:
16330115
12.

Endothelial function in the forearm circulation of patients with the metabolic syndrome--effect of different lipid-lowering regimens.

Bulut D, Hanefeld C, Bulut-Streich N, Graf C, Mügge A, Spiecker M.

Cardiology. 2005;104(4):176-80. Epub 2005 Sep 7.

PMID:
16155389
13.

Comparison of endothelial function in patients with metabolic syndrome on bezafibrate or atorvastatin therapy.

Hanefeld C, Bulut-Streich N, Bulut D, Graf C, Mügge A, Spiecker M.

Cardiovasc Drugs Ther. 2005 Mar;19(2):153-5. No abstract available.

PMID:
16025235
14.

Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.

Spiecker M, Liao JK.

Arch Biochem Biophys. 2005 Jan 15;433(2):413-20. Review.

PMID:
15581597
15.

Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.

Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Börgel J, Mügge A, Lindpaintner K, Huesing A, Maisch B, Zeldin DC, Liao JK.

Circulation. 2004 Oct 12;110(15):2132-6. Epub 2004 Oct 4.

16.
17.

Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study.

Neubauer H, Günesdogan B, Hanefeld C, Spiecker M, Mügge A.

Eur Heart J. 2003 Oct;24(19):1744-9.

PMID:
14522569
18.

Tranilast inhibits cytokine-induced nuclear factor kappaB activation in vascular endothelial cells.

Spiecker M, Lorenz I, Marx N, Darius H.

Mol Pharmacol. 2002 Oct;62(4):856-63.

PMID:
12237332
19.

Inhibition of major histocompatibility complex class II gene transcription by nitric oxide and antioxidants.

Grimm M, Spiecker M, De Caterina R, Shin WS, Liao JK.

J Biol Chem. 2002 Jul 19;277(29):26460-7. Epub 2002 May 10.

20.

Cloning of CYP2J2 gene and identification of functional polymorphisms.

King LM, Ma J, Srettabunjong S, Graves J, Bradbury JA, Li L, Spiecker M, Liao JK, Mohrenweiser H, Zeldin DC.

Mol Pharmacol. 2002 Apr;61(4):840-52.

PMID:
11901223
21.

Bolus Administration of Saruplase in Europe (BASE), a Pilot Study in Patients with Acute Myocardial Infarction.

Bär FW, Meyer J, Boland J, Betriu A, Artmeyer B, Charbonnier B, Michels HR, Tebbe U, Spiecker M, Vermeer F, von Fisenne MJ, Hopkins GR, Barth H.

J Thromb Thrombolysis. 1998 Sep;6(2):147-153.

PMID:
10751797
22.

A functional role of I kappa B-epsilon in endothelial cell activation.

Spiecker M, Darius H, Liao JK.

J Immunol. 2000 Mar 15;164(6):3316-22.

23.

NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression.

Lindemann S, Sharafi M, Spiecker M, Buerke M, Fisch A, Grosser T, Veit K, Gierer C, Ibe W, Meyer J, Darius H.

Thromb Res. 2000 Feb 1;97(3):113-23.

PMID:
10680642
24.

Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: five-year results of the PRIMI trial.

Spiecker M, Windeler J, Vermeer F, Michels R, Seabra-Gomes R, vom Dahl J, Kerber S, Verheugt FW, Westerhof PW, Bär FW, Nixdorff U, Barth H, Hopkins GR, von Fisenne MJ, Meyer J.

Am Heart J. 1999 Sep;138(3 Pt 1):518-24.

PMID:
10467203
25.

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK.

Science. 1999 Aug 20;285(5431):1276-9.

26.

The inhibition of endothelial activation by unsaturated fatty acids.

De Caterina R, Spiecker M, Solaini G, Basta G, Bosetti F, Libby P, Liao J.

Lipids. 1999;34 Suppl:S191-4. Review.

PMID:
10419145
27.

Assessing induction of I kappa B by nitric oxide.

Spiecker M, Liao JK.

Methods Enzymol. 1999;300:374-88. No abstract available.

PMID:
9919538
28.

Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation.

Peng HB, Spiecker M, Liao JK.

J Immunol. 1998 Aug 15;161(4):1970-6.

29.

Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants.

Spiecker M, Darius H, Kaboth K, Hübner F, Liao JK.

J Leukoc Biol. 1998 Jun;63(6):732-9.

PMID:
9620666
31.

In vitro analysis of synergistic effects of fibrinolytic agents and prostacyclin analogues.

Spiecker M, Heinke B, Meyer J, Darius H.

Haemostasis. 1997 Jul-Aug;27(4):184-92.

PMID:
9483173
32.

Detection of strands in native aortic valves by transesophageal echocardiography.

Menzel T, Mohr-Kahaly S, Arnold KJ, Kölsch B, Kopp H, Spiecker M, Wagner SR, Meinert R, Meyer J.

Am J Cardiol. 1997 Jun 1;79(11):1549-52.

PMID:
9185655
33.

Quantitative assessment of aortic stenosis by three-dimensional echocardiography.

Menzel T, Mohr-Kahaly S, Kölsch B, Kupferwasser I, Kopp H, Spiecker M, Wagner S, Meinert R, Pagnia F, Meyer J.

J Am Soc Echocardiogr. 1997 Apr;10(3):215-23.

PMID:
9109686
34.

Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction.

Bär FW, Meyer J, Vermeer F, Michels R, Charbonnier B, Haerten K, Spiecker M, Macaya C, Hanssen M, Heras M, Boland JP, Morice MC, Dunn FG, Uebis R, Hamm C, Ayzenberg O, Strupp G, Withagen AJ, Klein W, Windeler J, Hopkins G, Barth H, von Fisenne MJ.

Am J Cardiol. 1997 Mar 15;79(6):727-32.

PMID:
9070549
35.
36.

Quantification of mitral valve stenosis by three-dimensional transesophageal echocardiography.

Kupferwasser I, Mohr-Kahaly S, Menzel T, Spiecker M, Dohmen G, Mayer E, Oelert H, Erbel R, Meyer J.

Int J Card Imaging. 1996 Dec;12(4):241-7.

PMID:
8993986
37.

Sum of ST-segment elevations on admission electrocardiograms in acute myocardial infarction predicts left ventricular dilation.

Nixdorff U, Erbel R, Rupprecht HJ, Rill M, Spiecker M, Meyer J.

Am J Cardiol. 1996 Jun 1;77(14):1237-41.

PMID:
8651105
38.

Increased plasma concentration of fibrin monomer in acute myocardial infarction with early reperfusion.

Spiecker M, Hafner G, Nixdorff U, Prellwitz W, Meyer J.

Coron Artery Dis. 1996 Feb;7(2):155-60.

PMID:
8813448
39.

[PTCA-induced myocardial ischemia for detection salvaged myocardium after thrombolytic therapy of acute myocardial infarct].

Nixdorff U, Stein R, Erbel R, Rupprecht HJ, Spiecker M, Meyer J.

Z Kardiol. 1995 Jul;84(7):503-11. German.

PMID:
7676720
40.

[Significance of coronary perfusion for therapeutic success in myocardial infarct].

Spiecker M, Erbel R, Janssen H, Meyer J.

Herz. 1994 Dec;19(6):353-9. Review. German.

PMID:
7843691
41.

[Pro-urokinase for infarct therapy].

Spiecker M, Meyer J.

Herz. 1994 Dec;19(6):326-35. Review. German.

PMID:
7843689
44.

[Revascularization measures after acute myocardial infarct].

Erbel R, Spiecker M, Rupprecht HJ, Darius H, Görge G, Haude M, Dietz U, Meyer J.

Z Kardiol. 1993;82 Suppl 2:157-69. Review. German.

PMID:
8328196
45.

[Long-term follow-up of thrombolytic treatment of acute infarct in combination with acute and elective revascularization].

Spiecker M, Erbel R, Diefenbach C, Haidasch M, Treese N, Henrichs KJ, Rupprecht HJ, Pop T, Iversen S, Oelert H, et al.

Med Klin (Munich). 1992 Jul 15;87(7):343-9. German.

PMID:
1508114

Supplemental Content

Loading ...
Support Center